anemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced red blood cell (RBC) production - Often due to insufficient iron, vitamin B12, or folic acid, leading to fewer RBCs being made in the bone marrow, which decreases oxygen delivery to tissues.

• Secondary mechanism: Increased RBC destruction - Conditions like hemolytic anemia cause the body to destroy RBCs faster than they can be produced, leading to a shortage of healthy RBCs.

• Key complication: Tissue hypoxia - The resulting lack of adequate RBCs and hemoglobin means less oxygen is transported to body tissues, causing fatigue, weakness, and shortness of breath.

Patient Profile

Demographics:

32-year-old female, elementary school teacher

History:

• Key past medical history: Iron deficiency anemia diagnosed 2 years ago

• Current medications: Ferrous sulfate 325 mg once daily

• Allergies: None known

Current Presentation:

• Chief complaint: Fatigue and mild shortness of breath on exertion

• Key symptoms: Low energy levels, pale skin

• Vital signs: Blood pressure 118/76 mmHg, Heart rate 82 bpm, Respiratory rate 16 breaths per minute, Temperature 98.6°F, Oxygen saturation 98% on room air

Section 1

Initial Assessment Findings:

Upon further assessment, the nurse notes that the patient appears pale, especially around the nail beds and mucous membranes, which is consistent with her history of iron deficiency anemia. The patient reports feeling more fatigued in the afternoons, which significantly impacts her ability to manage her classroom effectively. She denies any recent changes in diet or lifestyle that could have contributed to this increased fatigue, and she has been adherent to her prescribed ferrous sulfate regimen. During a focused physical examination, the nurse observes no significant lymphadenopathy or hepatosplenomegaly. The patient's heart sounds are regular, and her lung fields are clear without any adventitious sounds.

Laboratory tests are ordered to evaluate the current status of her anemia. A Complete Blood Count (CBC) reveals a hemoglobin level of 10.5 g/dL and hematocrit of 32%, both slightly lower than normal, confirming the persistence of mild anemia. Her mean corpuscular volume (MCV) is 75 fL, indicating microcytic anemia, which aligns with her history of iron deficiency. Serum ferritin is measured at 15 ng/mL, suggesting low iron stores despite ongoing supplementation. Total iron binding capacity (TIBC) is elevated at 450 mcg/dL, further supporting the diagnosis of iron deficiency anemia.

These findings guide the healthcare team to re-evaluate her current iron supplementation strategy and dietary intake. They consider increasing her dietary intake of iron-rich foods and addressing potential factors that may hinder iron absorption, such as concurrent intake of calcium-rich foods or caffeine. The team also plans to monitor her symptoms closely and reassess her laboratory values in a few weeks to determine the effectiveness of the adjusted management plan. This will help ensure that her anemia is being addressed effectively, minimizing the impact on her daily activities and overall quality of life.

Section 2

Response to Interventions:

Two weeks after adjusting her iron supplementation strategy and dietary intake, the patient returns for a follow-up visit. She reports feeling slightly more energetic during the afternoons, although she still experiences some fatigue by the end of the workday. She has been diligently following the dietary recommendations, increasing her intake of iron-rich foods like lean meats and leafy greens while being mindful of separating her iron supplement from calcium-rich meals and caffeine consumption. Her adherence is commendable, and she expresses optimism about her gradual improvement.

During the physical examination, the nurse notes a slight improvement in the patient’s pallor, particularly around the mucous membranes. Her vital signs are stable, with a heart rate of 78 beats per minute and blood pressure at 118/76 mmHg. There are no new findings on auscultation of the heart and lungs, and her abdomen remains soft and non-tender with no organomegaly. The nurse takes note of these subtle positive changes and encourages the patient to continue her current regimen.

New laboratory results reveal a hemoglobin level of 11.2 g/dL and a hematocrit of 34%, indicating a modest improvement in her anemia. The mean corpuscular volume (MCV) has slightly increased to 77 fL, suggesting an early response to the increased iron intake. Serum ferritin levels have risen to 20 ng/mL, showing improved iron stores, although there is still room for enhancement. The healthcare team decides to maintain the current intervention plan, emphasizing the importance of ongoing dietary adjustments and observance of supplement timing. They plan to reassess her progress in another 4-6 weeks to ensure continued positive trends and to further support her recovery.

Section 3

Four weeks later, the patient returns for her scheduled follow-up and shares that she feels noticeably more energetic and able to complete her daily activities with less fatigue. She continues to adhere to her dietary regimen and supplement schedule, which has positively impacted her overall well-being. During this visit, she mentions experiencing occasional mild headaches and a slight increase in heart palpitations, particularly in the late afternoon. She denies any new symptoms such as dizziness or shortness of breath.

The nurse conducts a thorough assessment, noting that the patient's pallor has further improved, with a healthier hue evident in her skin and mucous membranes. Her vital signs are stable: her heart rate is 80 beats per minute, and her blood pressure is 116/74 mmHg. The nurse notes that her respiratory rate is 16 breaths per minute, with no abnormalities detected during auscultation. The patient's abdomen remains soft and non-tender, with no palpable masses or organ enlargement. Recognizing the patient's mild symptoms of headaches and palpitations, the nurse discusses potential lifestyle modifications and stress management techniques that may alleviate these issues.

New laboratory results reveal further improvement, with a hemoglobin level of 12.1 g/dL and a hematocrit of 36%. The mean corpuscular volume (MCV) has increased to 80 fL, and serum ferritin levels have risen to 30 ng/mL, indicating continued replenishment of iron stores. These positive trends suggest that the current intervention strategy is effective, though the healthcare team decides to explore the possibility of adjusting the iron supplement dosage if the patient's symptoms persist. They recommend scheduling another follow-up in 4-6 weeks to monitor her progress and address any ongoing concerns, ensuring a comprehensive approach to her recovery.

Section 4

Over the next few weeks, the patient diligently follows the care plan, incorporating stress management techniques into her daily routine, such as practicing deep breathing exercises and maintaining a balanced schedule to minimize late afternoon fatigue. At her next follow-up appointment, the nurse conducts an initial assessment, noting that the patient appears more vibrant and engaged. The patient reports that her headaches have become less frequent and less intense, and the palpitations have subsided significantly. She attributes these improvements to her newfound lifestyle modifications and adherence to the dietary and supplement regimen.

During the physical examination, the nurse observes that the patient's skin tone has maintained its healthier appearance, and there is no evidence of pallor in her conjunctivae or nail beds. Her vital signs remain stable, with a heart rate of 78 beats per minute and blood pressure at 114/72 mmHg. Her respiratory rate continues to be 16 breaths per minute, with clear lung sounds upon auscultation. The nurse palpates the abdomen and finds it soft and non-tender, consistent with previous assessments. Encouraged by these findings, the healthcare team agrees to maintain the current dosage of iron supplements while continuing to monitor the patient's progress closely.

The latest laboratory results further confirm the patient's positive trajectory. Her hemoglobin level has increased to 12.5 g/dL, and hematocrit is now 37%, indicating a steady recovery. The mean corpuscular volume (MCV) has normalized at 82 fL, and serum ferritin levels have reached 35 ng/mL, demonstrating adequate iron replenishment. The nurse reinforces the importance of continuing the treatment plan and scheduling regular follow-ups to ensure sustained improvement. With these advancements, the patient feels optimistic about her ongoing recovery and the management of her anemia. The healthcare team plans to reassess in six weeks, providing a continued supportive framework to address any potential fluctuations or concerns.

Section 5

Six weeks later, the patient returns for her follow-up appointment, eager to discuss her continued progress. During the initial assessment, the nurse notices that the patient maintains her vibrant appearance and continues to report fewer symptoms related to anemia. She mentions that her energy levels have improved significantly, and she no longer experiences late afternoon fatigue. Her adherence to the care plan, including dietary adjustments and stress management techniques, remains strong.

Upon examination, the nurse finds that the patient's vital signs are stable: her heart rate is 76 beats per minute, and blood pressure is 112/70 mmHg. Her respiratory rate is 16 breaths per minute, with clear lung sounds. The patient’s skin tone remains healthy, and there is no pallor in her conjunctivae or nail beds, indicating the maintenance of adequate oxygenation and perfusion. The abdominal assessment shows no changes, with the abdomen remaining soft and non-tender.

The latest laboratory results support the continued positive trend in the patient's condition. Her hemoglobin level has increased slightly to 13.0 g/dL, and hematocrit is now at 39%, both within normal ranges for her age and sex. The mean corpuscular volume (MCV) is stable at 84 fL, and serum ferritin has reached 40 ng/mL, confirming sufficient iron stores. The healthcare team decides to continue the current treatment plan, with a focus on transitioning to a maintenance phase to prevent recurrence. The patient is instructed to continue her iron supplements at a lower dose and to maintain her dietary habits. A follow-up appointment is scheduled for three months later to ensure her condition remains stable and to address any potential concerns that may arise.